298 related articles for article (PubMed ID: 28871078)
1. Impact of Forced Expiratory Volume in 1 Second (FEV1) and 6-Minute Walking Distance at 3, 6, and 12 Months and Annually on Survival and Occurrence of Bronchiolitis Obliterans Syndrome (BOS) After Lung Transplantation.
Fakhro M; Ingemansson R; Algotsson L; Lindstedt S
Ann Transplant; 2017 Sep; 22():532-540. PubMed ID: 28871078
[TBL] [Abstract][Full Text] [Related]
2. Double lung, unlike single lung transplantation might provide a protective effect on mortality and bronchiolitis obliterans syndrome.
Fakhro M; Broberg E; Algotsson L; Hansson L; Koul B; Gustafsson R; Wierup P; Ingemansson R; Lindstedt S
J Cardiothorac Surg; 2017 Nov; 12(1):100. PubMed ID: 29178919
[TBL] [Abstract][Full Text] [Related]
3. Post-transplant baseline FEV1 and the development of bronchiolitis obliterans syndrome: an important confounder?
Burton CM; Iversen M; Mortensen J; Carlsen J; Andersen CB; Milman N; Scheike T
J Heart Lung Transplant; 2007 Nov; 26(11):1127-34. PubMed ID: 18022078
[TBL] [Abstract][Full Text] [Related]
4. Machine Learning Algorithms Utilizing Quantitative CT Features May Predict Eventual Onset of Bronchiolitis Obliterans Syndrome After Lung Transplantation.
Barbosa EJM; Lanclus M; Vos W; Van Holsbeke C; De Backer W; De Backer J; Lee J
Acad Radiol; 2018 Sep; 25(9):1201-1212. PubMed ID: 29472146
[TBL] [Abstract][Full Text] [Related]
5. Bronchiolitis obliterans syndrome-free survival after lung transplantation: An International Society for Heart and Lung Transplantation Thoracic Transplant Registry analysis.
Kulkarni HS; Cherikh WS; Chambers DC; Garcia VC; Hachem RR; Kreisel D; Puri V; Kozower BD; Byers DE; Witt CA; Alexander-Brett J; Aguilar PR; Tague LK; Furuya Y; Patterson GA; Trulock EP; Yusen RD
J Heart Lung Transplant; 2019 Jan; 38(1):5-16. PubMed ID: 30391193
[TBL] [Abstract][Full Text] [Related]
6. Evolution of Functional Exercise Capacity in Lung Transplant Patients With and Without Bronchiolitis Obliterans Syndrome: A Longitudinal Case-Control Study.
Cebrià I Iranzo MÀ; Vos R; Verleden GM; Gosselink R; Langer D
Arch Bronconeumol (Engl Ed); 2019 May; 55(5):239-245. PubMed ID: 30595421
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and outcome of bronchiolitis obliterans syndrome after lung transplantation. Washington University Lung Transplant Group.
Sundaresan S; Trulock EP; Mohanakumar T; Cooper JD; Patterson GA
Ann Thorac Surg; 1995 Nov; 60(5):1341-6; discussion 1346-7. PubMed ID: 8526624
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of the 6min walk test in bronchiolitis obliterans syndrome.
Nathan SD; Shlobin OA; Reese E; Ahmad S; Fregoso M; Athale C; Barnett SD
Respir Med; 2009 Dec; 103(12):1816-21. PubMed ID: 19682883
[TBL] [Abstract][Full Text] [Related]
9. Single-lung transplantation: does side matter?
Tsagkaropoulos S; Belmans A; Verleden GM; Coosemans W; Decaluwe H; De Leyn P; Nafteux P; Van Raemdonck D
Eur J Cardiothorac Surg; 2011 Aug; 40(2):e83-92. PubMed ID: 21497108
[TBL] [Abstract][Full Text] [Related]
10. Impact of graft colonization with gram-negative bacteria after lung transplantation on the development of bronchiolitis obliterans syndrome in recipients with cystic fibrosis.
Gottlieb J; Mattner F; Weissbrodt H; Dierich M; Fuehner T; Strueber M; Simon A; Welte T
Respir Med; 2009 May; 103(5):743-9. PubMed ID: 19117741
[TBL] [Abstract][Full Text] [Related]
11. Sustained-Release Tacrolimus Stabilizes Decline of Forced Expiratory Volume in 1 Second Through Decreasing Fluctuation of Its Trough Blood Level.
Matsuda Y; Eba S; Hoshi F; Oishi H; Sado T; Noda M; Sakurada A; Watanabe T; Niikawa H; Akiba M; Okada Y
Transplant Proc; 2018 Nov; 50(9):2768-2770. PubMed ID: 30401394
[TBL] [Abstract][Full Text] [Related]
12. Long-term azithromycin for bronchiolitis obliterans syndrome after lung transplantation.
Gottlieb J; Szangolies J; Koehnlein T; Golpon H; Simon A; Welte T
Transplantation; 2008 Jan; 85(1):36-41. PubMed ID: 18192909
[TBL] [Abstract][Full Text] [Related]
13. Bronchiolitis obliterans syndrome: incidence, natural history, prognosis, and risk factors.
Heng D; Sharples LD; McNeil K; Stewart S; Wreghitt T; Wallwork J
J Heart Lung Transplant; 1998 Dec; 17(12):1255-63. PubMed ID: 9883768
[TBL] [Abstract][Full Text] [Related]
14. Long-term health-related quality of life and walking capacity of lung recipients with and without bronchiolitis obliterans syndrome.
Gerbase MW; Soccal PM; Spiliopoulos A; Nicod LP; Rochat T
J Heart Lung Transplant; 2008 Aug; 27(8):898-904. PubMed ID: 18656804
[TBL] [Abstract][Full Text] [Related]
15. Lung Function Trajectory in Bronchiolitis Obliterans Syndrome after Allogeneic Hematopoietic Cell Transplant.
Cheng GS; Storer B; Chien JW; Jagasia M; Hubbard JJ; Burns L; Ho VT; Pidala J; Palmer J; Johnston L; Mayer S; Crothers K; Pusic I; Lee SJ; Williams KM
Ann Am Thorac Soc; 2016 Nov; 13(11):1932-1939. PubMed ID: 27513368
[TBL] [Abstract][Full Text] [Related]
16. Prognostic role of FEV1 for survival in bronchiolitis obliterans syndrome after allogeneic hematopoietic stem cell transplantation.
Ahn JH; Jo KW; Song JW; Shim TS; Lee SW; Lee JS; Kim DY; Lee JH; Lee JH; Choi Y; Lee KH
Clin Transplant; 2015 Dec; 29(12):1133-9. PubMed ID: 26383085
[TBL] [Abstract][Full Text] [Related]
17. Combined diffusing capacity for nitric oxide and carbon monoxide as predictor of bronchiolitis obliterans syndrome following lung transplantation.
Winkler A; Kahnert K; Behr J; Neurohr C; Kneidinger N; Hatz R; Dressel H; Radtke T; Jörres RA
Respir Res; 2018 Sep; 19(1):171. PubMed ID: 30200966
[TBL] [Abstract][Full Text] [Related]
18. Gastroesophageal reflux in bronchiolitis obliterans syndrome: a new perspective.
King BJ; Iyer H; Leidi AA; Carby MR
J Heart Lung Transplant; 2009 Sep; 28(9):870-5. PubMed ID: 19716037
[TBL] [Abstract][Full Text] [Related]
19. Potential functional and survival benefit of double over single lung transplantation for selected patients with idiopathic pulmonary fibrosis.
Neurohr C; Huppmann P; Thum D; Leuschner W; von Wulffen W; Meis T; Leuchte H; Baumgartner R; Zimmermann G; Hatz R; Czerner S; Frey L; Ueberfuhr P; Bittmann I; Behr J;
Transpl Int; 2010 Sep; 23(9):887-96. PubMed ID: 20230541
[TBL] [Abstract][Full Text] [Related]
20. Acute cellular rejection is a risk factor for bronchiolitis obliterans syndrome independent of post-transplant baseline FEV1.
Burton CM; Iversen M; Carlsen J; Mortensen J; Andersen CB; Steinbrüchel D; Scheike T
J Heart Lung Transplant; 2009 Sep; 28(9):888-93. PubMed ID: 19716040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
